BioWorld5d
Combining KAT6A/B inhibitor and retinoic acid shows efficacy in neuroblastoma models
Neuroblastoma, an aggressive malignancy originating from neural crest cells, accounts for 15% of cancer-related deaths in children. Treatment strategies include systemic chemotherapy, radiation or ...
Pharmaceutical Technology on MSN7d
Insilico raises $110m to develop drug pipeline and AI platform
The company’s focus will be on progressing the clinical validation of its idiopathic pulmonary fibrosis treatment.
BioWorld9d
Shanghai Henlius Biologics divulges new KAT6A and KAT6B inhibitors
Shanghai Henlius Biologics Co. Ltd. has synthesized histone acetyltransferase KAT6A (monocytic leukemia zinc finger protein; MOZ; MYST-3) and/or histone acetyltransferase KAT6B (MOZ2; MYST-4) ...
SBS3y
"He was the second case in Sydney", Japanese mum tries to raise awareness of a rare genetic disorder KAT6A Syndrome
Sydney-based Japanese mum Ryoko Tacadena has a 3-year-old son, Shinji, who has a rare genetic disorder called KAT6A Syndrome. Sydney-based Japanese mum Ryoko Tacadena has a 3-year-old son ...